+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 200 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899526
The global induced pluripotent stem cells production market size is estimated to reach USD 2.76 billion by 2030. The market is expected to expand at a CAGR of 9.3% from 2023 to 2030. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights

  • By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share of 77.2% in 2022.
  • By workflow, the cell culture segment dominated the market with the largest revenue share of 37.3% in 2022. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.
  • By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.3% in 2022. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
  • By application, drug development & discovery segment dominated the market with the largest revenue share of 43.3% in 2022.
  • By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.3% in 2022. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
  • North America dominated the market and accounted for the largest revenue share of 40.8% in 2022. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Process
1.1.2. Workflow
1.1.3. Product
1.1.4. Application
1.1.5. End use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Process outlook
2.2.2. Workflow outlook
2.2.3. Product outlook
2.2.4. Application outlook
2.2.5. End use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Induced Pluripotent Stem Cells Production Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Induced Pluripotent Stem Cells Production Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Induced Pluripotent Stem Cells Production: Process Estimates & Trend Analysis
4.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
4.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Manual iPSC Production Process
4.3.1. Manual iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Automated iPSC Production Process
4.4.1. Automated iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Induced Pluripotent Stem Cells Production: Workflow Estimates & Trend Analysis
5.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
5.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Reprogramming
5.3.1. Reprogramming market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cell Culture
5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cell Characterization /Analysis
5.5.1. Cell characterization /analysis market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Engineering
5.6.1. Engineering market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Induced Pluripotent Stem Cells Production: Product Estimates & Trend Analysis
6.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
6.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Instruments/Devices
6.3.1. Instruments/devices market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Automated Platforms
6.4.1. Automated platforms market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Consumables & Kits
6.5.1. Consumables & kits market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Media
6.5.2.1. Media market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Kits
6.5.3.1. Kits market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. Others
6.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Services
6.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Induced Pluripotent Stem Cells Production: Application Estimates & Trend Analysis
7.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
7.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Drug Development & Discovery
7.3.1. Drug development & discovery market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Regenerative Medicine
7.4.1. Regenerative medicine market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Toxicology Studies
7.5.1. Toxicology studies market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Induced Pluripotent Stem Cells Production: End Use Estimates & Trend Analysis
8.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
8.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
8.3. Research & Academic Institutes
8.3.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Biotechnology & Pharmaceutical Companies
8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Hospitals & Clinics
8.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Induced Pluripotent Stem Cells Production: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. Induced Pluripotent Stem Cells Production Market by Region: Key Marketplace Takeaway
9.3. North America
9.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.3.3. Canada
9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4. Europe
9.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.2. UK
9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.3. Germany
9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.4. France
9.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.5. Italy
9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.6. Spain
9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.7. Sweden
9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.8. Norway
9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.9. Denmark
9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.2. Japan
9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.3. China
9.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.4. India
9.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.5. Australia
9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.6. Thailand
9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.7. South Korea
9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6. Latin America
9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.2. Brazil
9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.3. Mexico
9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.4. Argentina
9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7. MEA
9.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.3. South Africa
9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.4. UAE
9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.5. Kuwait
9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Market Participant Categorization
10.2.1. Lonza
10.2.1.1. Company overview
10.2.1.2. Financial performance
10.2.1.3. Product benchmarking
10.2.1.4. Strategic initiatives
10.2.2. Axol Biosciences Ltd.
10.2.2.1. Company overview
10.2.2.2. Financial performance
10.2.2.3. Product benchmarking
10.2.2.4. Strategic initiatives
10.2.3. Evotec Se
10.2.3.1. Company overview
10.2.3.2. Financial performance
10.2.3.3. Product benchmarking
10.2.3.4. Strategic initiatives
10.2.4. Hitachi Ltd.
10.2.4.1. Company overview
10.2.4.2. Financial performance
10.2.4.3. Product benchmarking
10.2.4.4. Strategic initiatives
10.2.5. Reprocells Inc.
10.2.5.1. Company overview
10.2.5.2. Financial performance
10.2.5.3. Product benchmarking
10.2.5.4. Strategic initiatives
10.2.6. Fate Therapeutics
10.2.6.1. Company overview
10.2.6.2. Financial performance
10.2.6.3. Product benchmarking
10.2.6.4. Strategic initiatives
10.2.7. Thermo Fisher Scientific, Inc.
10.2.7.1. Company overview
10.2.7.2. Financial performance
10.2.7.3. Product benchmarking
10.2.7.4. Strategic initiatives
10.2.8. Merck Kgaa
10.2.8.1. Company overview
10.2.8.2. Financial performance
10.2.8.3. Product benchmarking
10.2.8.4. Strategic initiatives
10.2.9. StemCellsFactory III
10.2.9.1. Company overview
10.2.9.2. Financial performance
10.2.9.3. Product benchmarking
10.2.9.4. Strategic initiatives
10.2.10. Applied StemCells, Inc.
10.2.10.1. Company overview
10.2.10.2. Financial performance
10.2.10.3. Product benchmarking
10.2.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 3 North America induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 4 North America induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 5 North America induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 6 North America induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 7 North America induced pluripotent stem cells production market, by region, 2018-2030 (USD Million)
Table 8 U.S. induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 9 U.S. induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 10 U.S. induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 11 U.S. induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 12 U.S. induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 13 Canada induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 14 Canada induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 15 Canada induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 16 Canada induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 17 Canada induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 18 Europe induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 19 Europe induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 20 Europe induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 21 Europe induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 22 Europe induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 23 Europe induced pluripotent stem cells production market, by region, 2018-2030 (USD Million)
Table 24 Germany induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 25 Germany induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 26 Germany induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 27 Germany induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 28 Germany induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 29 UK induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 30 UK induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 31 UK induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 32 UK induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 33 UK induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 34 France induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 35 France induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 36 France induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 37 France induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 38 France induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 39 Italy induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 40 Italy induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 41 Italy induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 42 Italy induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 43 Italy induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 44 Spain induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 45 Spain induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 46 Spain induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 47 Spain induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 48 Spain induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 49 Sweden induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 50 Sweden induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 51 Sweden induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 52 Sweden induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 53 Sweden induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 54 Norway induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 55 Norway induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 56 Norway induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 57 Norway induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 58 Norway induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 59 Norway induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 60 Denmark induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 61 Denmark induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 62 Denmark induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 63 Denmark induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 64 Asia Pacific induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 65 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 66 Asia Pacific induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 67 Asia Pacific induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 68 Asia Pacific induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 69 Asia Pacific induced pluripotent stem cells production market, by region, 2018-2030 (USD Million)
Table 70 China induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 71 China induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 72 China induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 73 China induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 74 China induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 75 Japan induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 76 Japan induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 77 Japan induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 78 Japan induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 79 Japan induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 80 India induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 81 India induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 82 India induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 83 India induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 84 India induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 85 Australia induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 86 Australia induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 87 Australia induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 88 Australia induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 89 Australia induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 90 Thailand induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 91 Thailand induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 92 Thailand induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 93 Thailand induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 94 Thailand induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 95 South Korea induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 96 South Korea induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 97 South Korea induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 98 South Korea induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 99 South Korea induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 100 Latin America induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 101 Latin America induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 102 Latin America induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 103 Latin America induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 104 Latin America induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 105 Latin America induced pluripotent stem cells production market, by region, 2018-2030 (USD Million)
Table 106 Brazil induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 107 Brazil induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 108 Brazil induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 109 Brazil induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 110 Brazil induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 111 Mexico induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 112 Mexico induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 113 Mexico induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 114 Mexico induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 115 Mexico induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 116 Argentina induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 117 Argentina induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 118 Argentina induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 119 Argentina induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 120 Argentina induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 121 Middle East and Africa induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 122 Middle East and Africa induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 123 Middle East and Africa induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 124 Middle East and Africa induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 125 Middle East and Africa induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 126 Middle East and Africa induced pluripotent stem cells production market, by region, 2018-2030 (USD Million)
Table 127 South Africa induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 128 South Africa induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 129 South Africa induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 130 South Africa induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 131 South Africa induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 132 Saudi Arabia induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 133 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 134 Saudi Arabia induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 135 Saudi Arabia induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 136 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 137 UAE induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 138 UAE induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 139 UAE induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 140 UAE induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 141 UAE induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
Table 142 Kuwait induced pluripotent stem cells production market, by process, 2018-2030 (USD Million)
Table 143 Kuwait induced pluripotent stem cells production market, by workflow, 2018-2030 (USD Million)
Table 144 Kuwait induced pluripotent stem cells production market, by product, 2018-2030 (USD Million)
Table 145 Kuwait induced pluripotent stem cells production market, by application, 2018-2030 (USD Million)
Table 146 Kuwait induced pluripotent stem cells production market, by end use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Induced pluripotent stem cells production: Market outlook
Fig. 8 Induced pluripotent stem cells production: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Induced pluripotent stem cells production market driver impact
Fig. 14 Induced pluripotent stem cells production market restraint impact
Fig. 15 Induced pluripotent stem cells production market strategic initiatives analysis
Fig. 16 Induced pluripotent stem cells production market: Process movement analysis
Fig. 17 Induced pluripotent stem cells production market: Process outlook and key takeaways
Fig. 18 Manual iPSC production process estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Automated iPSC production process estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Induced pluripotent stem cells production market: Workflow movement analysis
Fig. 21 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
Fig. 22 Reprogramming market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 Cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 24 Cell characterization / analysis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Engineering market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Induced pluripotent stem cells production market: Product movement analysis
Fig. 28 Induced pluripotent stem cells production market: Product outlook and key takeaways
Fig. 29 Instruments/ devices market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 Automated platforms market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Consumables & kits market estimates and forecasts, 2018-2030
Fig. 32 Media market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Kits market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Services market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Induced pluripotent stem cells production market: Application movement analysis
Fig. 37 Induced pluripotent stem cells production market: Application outlook and key takeaways
Fig. 38 Drug development and discovery market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Regenerative medicine market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Toxicology studies market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Others market estimates and forecasts, 2018-2030
Fig. 42 Induced pluripotent stem cells production market: End use movement analysis
Fig. 43 Induced pluripotent stem cells production market: End use outlook and key takeaways
Fig. 44 Research & academic institutes market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Hospitals & clinics market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Global Induced pluripotent stem cells production market: Regional movement analysis
Fig. 48 Global Induced pluripotent stem cells production market: Regional outlook and key takeaways
Fig. 49 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 67 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 69 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 71 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 73 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 75 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Lonza
  • Axol Biosciences Ltd.
  • Evotec Se
  • Hitachi Ltd.
  • Reprocells Inc.
  • Fate Therapeutics
  • Thermo Fisher Scientific, Inc.
  • Merck Kgaa
  • StemCellsFactory III
  • Applied StemCells, Inc.

Methodology

Loading
LOADING...

Table Information